References
Contribution to Allergy (2004 – 2015)
Annemie Narkus. Validation and suitability of the Allergy-Control-SCORE (ACS©). 14th International Paul-Ehrlich-Seminar 2014, Bad Nauheim. www.pei.de/ipes2014.
www.pei.de/ipes2014
Klimek L, Bachert C, Lukat K F, Pfaar O, Meyer H, Narkus A. Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial. Clin Transl Allergy 2015; 5:28. doi: 10.1186/s13601-015-0071-x. eCollection@2015.: 28-0071.
www.pubmed.de/data/nlm.link.html
Häfner D, Gödicke V, Narkus A. Allergen specific immunotherapy has no influence on standard chemistry and hematology laboratory parameters in clinical studies. Clin Transl Allergy 2014; 4(18): 1-14.
www.pubmed.de/data/nlm.link.html
Meyer W, Narkus A, Salapatek A M, Häfner D. Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber. Allergy 2013; 68(6): 724-731.
www.pubmed.de/data/nlm.link.html
Narkus A, Lehnigk U, Haefner D, Klinger R, Pfaar O, Worm M. The placebo effect in allergen-specific immunotherapy trials. Clin Transl Allergy 2013; 3(1): 42.
www.pubmed.de/data/nlm.link.html
Häfner D, Reich K, Zschocke I, Lotzin A, Meyer H, Kettner J, Narkus A. Prospective validation of the „rhino conjunctivitis allergy-control-SCORE(c)“ (RC-ACS(c)). Clin Transl Allergy 2012; 2(17): 1-8.
www.pubmed.de/data/nlm.link.html
Häfner D, Reich K, Matricardi P M, Meyer H, Kettner J, Narkus A. Prospective validation of ‚Allergy-Control-SCORE(TM) ‚: a novel symptom-medication score for clinical trials. Allergy 2011; 66(5): 629-636.
www.pubmed.de/data/nlm.link.html
Matricardi P M, Kuna P, Panetta V, Wahn U, Narkus A. Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: A comparison based on meta-analyses. J Allergy Clin Immunol 2011; 128(4): 791-799.
www.pubmed.de/data/nlm.link.html
Cromwell O, Fiebig H, Suck R, Kahlert H, Nandy A, Kettner J, Narkus A. Strategies for recombinant allergen vaccines and fruitful results from first clinical studies. Immunol Allergy Clin N Amer 2006; 26(2): 261-281.
Corrigan C J, Kettner J, Doemer C, Cromwell O, Narkus A. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy 2005; 60(6): 801-807.
www.pubmed.de/data/nlm.link.html